High-mobility group nucleosome-binding domain 2 protein inhibits the invasion of Klebsiella pneumoniae into mouse lungs in vivo

Molecular Medicine Reports
Shuang ZhengNing Huang

Abstract

Since bacterial invasion into host cells is a critical step in the infection process and the predominance of multiple-antibiotic-resistant Klebsiella (K.) pneumoniae strains, using molecular agents to interfere with K. pneumoniae invasion is an attractive approach for the prevention of infection and suppress the immune inflammatory response. In previous studies by our group, high-mobility group nucleosome-binding domain 2 (HMGN2) protein was shown to exhibit anti-bacterial activity in vitro. The objective of the present study was to investigate the effects of HMGN2 protein on the invasion of K. pneumoniae 03183 in vivo. The results showed that pre-treatment with 128 µg/ml HMGN2 significantly reduced K. pneumoniae 03183 invasion into mouse lungs and increased the mRNA expression of CXCL1 and LCN2 within 2 h. Immunohistochemical staining showed that F-actin expression was significantly decreased, and fluorescence microscopy and western blot analysis further demonstrated that HMGN2 significantly blocked K. pneumoniae 03183-induced actin polymerization. These changes implied that HMGN2 may provide protection against K. pneumoniae 03183 infection in vivo.

References

Apr 1, 1992·The Journal of Antimicrobial Chemotherapy·W R Jarvis, W J Martone
Jul 1, 1990·Reviews of Infectious Diseases·J L Carpenter
Jun 1, 1985·The Journal of Antimicrobial Chemotherapy·E Kihlström, L Andåker
Aug 22, 2000·The Journal of Experimental Medicine·U AnderssonK J Tracey
Sep 7, 2000·The Journal of Biological Chemistry·H ShirakawaY Postnikov
Oct 6, 2001·American Journal of Respiratory Cell and Molecular Biology·P YeJ K Kolls
Feb 20, 2003·The Journal of Allergy and Clinical Immunology·Larry C Borish, John W Steinke
Apr 18, 2003·Nature·Samantha Gruenheid, B Brett Finlay
Sep 2, 2003·Nature Reviews. Immunology·Tomas Ganz
Feb 11, 2005·Journal of Cell Science·Steven J Winder, Kathryn R Ayscough
Apr 21, 2005·Cellular Microbiology·Frank Lafont, F Gisou van der Goot
Oct 6, 2005·Journal of Leukocyte Biology·Yun FengBoyao Wang
Aug 22, 2007·Cell Host & Microbe·Jeongmin SongSoman N Abraham
Oct 19, 2007·Nature·Amit P BhavsarB Brett Finlay
Jul 5, 2008·Arthritis Research & Therapy·David S PisetskyUlf Andersson
Oct 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rachel E SutherlandPaul J Wolters
Oct 22, 2009·The FEBS Journal·Mangalam SubramanianMichael Bergel
Oct 13, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shanshan CaiSamithamby Jeyaseelan
Aug 5, 2011·The Journal of Biological Chemistry·Atsushi NoharaMasatomo Mori
Oct 5, 2011·The Journal of Cell Biology·Cat M Haglund, Matthew D Welch

❮ Previous
Next ❯

Citations

Jan 16, 2020·International Journal of Molecular Sciences·Ravikanth NanduriMichael Bustin
Oct 28, 2021·International Microbiology : the Official Journal of the Spanish Society for Microbiology·Ali QasemiMohammad Katouli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.